Antiangiogenic agents (Q33796285)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antiangiogenic agents	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Antiangiogenic agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

author name string

Klohs WD

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hamby JM

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Current Opinion in Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

544-549

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Molecular mechanisms of tumor metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging therapeutic targets in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Manipulating angiogenesis. From basic science to the bedside.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure of human methionine aminopeptidase-2 complexed with fumagillin

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiostatin binds ATP synthase on the surface of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Endostatin induces endothelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2900033-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0958-1669(99)00033-6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33796285&oldid=1765262064"